Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
Skeletal Radiol ; 53(3): 499-506, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-37668679

RESUMEN

OBJECTIVE: The main objective of this study was to understand the role of skeletal maturity in the different patterns of osteochondral and ligamentous injuries after an acute lateral patellar dislocation. MATERIALS AND METHODS: Two radiologists independently reviewed MRIs of 212 knees performed after an acute lateral patellar dislocation to evaluate the presence of high-grade patellar osteochondral injury, femoral osteochondral injury, and medial patellofemoral ligament injury. The association of skeletal maturity (indicated by a closed distal femoral physis), age, sex, and first-time versus recurrent dislocation with each of these various lesions was analyzed using Chi-square or T test, and multivariable logistic regression with estimation of odds ratios (OR). RESULTS: Skeletal maturity was significantly associated with high-grade patellar osteochondral injury [OR=2.72 (95% CI 1.00, 7.36); p=0.049] and femoral-side MPFL tear [OR=2.34 (95% CI 1.05, 5.25); p=0.039]. Skeletal immaturity was significantly associated with patellar-side MPFL tear [OR=0.35 (95% CI 0.14, 0.90); p=0.029]. CONCLUSION: Patterns of injury to the patella and medial patellofemoral ligament vary notably between the skeletally immature and mature, and these variations may be explained by the inherent weakness of the patellar secondary physis.


Asunto(s)
Laceraciones , Luxación de la Rótula , Articulación Patelofemoral , Humanos , Luxación de la Rótula/diagnóstico por imagen , Rótula/diagnóstico por imagen , Rótula/patología , Articulación de la Rodilla/diagnóstico por imagen , Articulación de la Rodilla/patología , Fémur , Ligamentos Articulares/lesiones , Rotura/complicaciones
2.
Radiographics ; 41(2): E20-E39, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33646909

RESUMEN

A variety of sports require exposure to high-impact trauma or characteristic repetitive movements that predispose to injuries around the thorax. Appropriate prognostication and timely management are vital, as untreated or undertreated injuries can lead to pain, disability, loss of playing time, or early termination of sports participation. The authors review common athletic injuries of the thoracic cage, encompassing muscular, osseous, and vascular conditions, with an emphasis on mechanism, imaging features, and management. The authors also review pertinent soft-tissue and bony anatomy, along with relevant sports biomechanics. Generalized muscle trauma and more specific injuries involving the pectoralis major, latissimus dorsi, teres major, pectoralis minor, lateral abdominal wall and intercostals, serratus anterior, and rectus abdominis muscles are discussed. Osseous injuries such as stress fractures, sternoclavicular dislocation, costochondral fractures, and scapular fractures are included. Finally, thoracic conditions such as snapping scapula, thoracic outlet syndrome, and Paget-Schroetter syndrome are also described. Specific MRI protocols are highlighted to address imaging challenges such as the variable anatomic orientation of thoracic structures and artifact from breathing motion. Athletes are susceptible to a wide range of musculoskeletal thoracic trauma. An accurate imaging diagnosis of thoracic cage injury and assessment of injury severity allow development of an adequate treatment plan. This can be facilitated by an understanding of functional anatomy, sports biomechanics, and the unique injuries for which athletes are at risk. ©RSNA, 2021.


Asunto(s)
Traumatismos en Atletas , Traumatismos de los Tejidos Blandos , Traumatismos Torácicos , Pared Torácica , Traumatismos en Atletas/diagnóstico por imagen , Humanos , Imagen por Resonancia Magnética , Caja Torácica , Traumatismos Torácicos/diagnóstico por imagen
3.
J Digit Imaging ; 33(5): 1209-1217, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32583277

RESUMEN

To use deep learning with advanced data augmentation to accurately diagnose and classify femoral neck fractures. A retrospective study of patients with femoral neck fractures was performed. One thousand sixty-three AP hip radiographs were obtained from 550 patients. Ground truth labels of Garden fracture classification were applied as follows: (1) 127 Garden I and II fracture radiographs, (2) 610 Garden III and IV fracture radiographs, and (3) 326 normal hip radiographs. After localization by an initial network, a second CNN classified the images as Garden I/II fracture, Garden III/IV fracture, or no fracture. Advanced data augmentation techniques expanded the training set: (1) generative adversarial network (GAN); (2) digitally reconstructed radiographs (DRRs) from preoperative hip CT scans. In all, 9063 images, real and generated, were available for training and testing. A deep neural network was designed and tuned based on a 20% validation group. A holdout test dataset consisted of 105 real images, 35 in each class. Two class prediction of fracture versus no fracture (AUC 0.92): accuracy 92.3%, sensitivity 0.91, specificity 0.93, PPV 0.96, NPV 0.86. Three class prediction of Garden I/II, Garden III/IV, or normal (AUC 0.96): accuracy 86.0%, sensitivity 0.79, specificity 0.90, PPV 0.80, NPV 0.90. Without any advanced augmentation, the AUC for two-class prediction was 0.80. With DRR as the only advanced augmentation, AUC was 0.91 and with GAN only AUC was 0.87. GANs and DRRs can be used to improve the accuracy of a tool to diagnose and classify femoral neck fractures.


Asunto(s)
Aprendizaje Profundo , Fracturas del Cuello Femoral , Fracturas del Cuello Femoral/diagnóstico por imagen , Humanos , Redes Neurales de la Computación , Radiografía , Estudios Retrospectivos
4.
Skeletal Radiol ; 49(8): 1249-1258, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32144449

RESUMEN

OBJECTIVE: To determine the prevalence of athletic pubalgia imaging findings on MRI in patients with femoroacetabular impingement and assess for correlative risk factors. MATERIALS AND METHODS: A retrospective search identified 156 hips with femoroacetabular impingement and a control group of 113 without femoroacetabular impingement that had an MRI performed between January 1, 2015, and January 1, 2018. Two fellowship-trained musculoskeletal radiologists reviewed studies for the presence of acute osteitis pubis, chronic osteitis pubis, adductor tendinosis, and tendon tear; rectus abdominis tendinosis and tendon tear; and aponeurotic plate tear. Findings were correlated with various clinical and imaging risk factors. Univariate and multivariate statistical analyses were performed. RESULTS: Imaging findings of adductor tendinosis (p = 0.02) and chronic osteitis pubis (p = 0.01) were more prevalent in FAI patients than controls. Univariate analyses in FAI patients showed that an alpha angle ≥ 60° had a higher prevalence of aponeurotic plate tears (p = 0.02) and adductor tendinosis (p = 0.049). Multivariate analyses showed that an alpha angle ≥ 60° had a higher prevalence of chronic osteitis pubis (OR = 2.27, p = 0.031), sports participation had a higher prevalence of adductor tendon tears (OR = 4.69, p = 0.013) and chronic osteitis pubis (OR = 2.61, p = 0.0058), and males had a higher prevalence of acute osteitis pubis (OR = 5.17, p = 0.032). CONCLUSION: Sports participation, alpha angle ≥ 60°, and male sex predict a higher prevalence of athletic pubalgia imaging findings in patients with femoroacetabular impingement.


Asunto(s)
Artralgia/diagnóstico por imagen , Traumatismos en Atletas/diagnóstico por imagen , Pinzamiento Femoroacetabular/complicaciones , Imagen por Resonancia Magnética/métodos , Osteítis/diagnóstico por imagen , Tendinopatía/diagnóstico por imagen , Adulto , Estudios de Casos y Controles , Femenino , Ingle , Humanos , Masculino , Prevalencia , Estudios Retrospectivos , Factores de Riesgo
5.
J Am Med Inform Assoc ; 25(5): 507-514, 2018 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-29092054

RESUMEN

Objective: To describe types of recommendations represented in a curated online evidence library, report on the quality of evidence-based recommendations pertaining to diagnostic imaging exams, and assess underlying knowledge representation. Materials and Methods: The evidence library is populated with clinical decision rules, professional society guidelines, and locally developed best practice guidelines. Individual recommendations were graded based on a standard methodology and compared using chi-square test. Strength of evidence ranged from grade 1 (systematic review) through grade 5 (recommendations based on expert opinion). Finally, variations in the underlying representation of these recommendations were identified. Results: The library contains 546 individual imaging-related recommendations. Only 15% (16/106) of recommendations from clinical decision rules were grade 5 vs 83% (526/636) from professional society practice guidelines and local best practice guidelines that cited grade 5 studies (P < .0001). Minor head trauma, pulmonary embolism, and appendicitis were topic areas supported by the highest quality of evidence. Three main variations in underlying representations of recommendations were "single-decision," "branching," and "score-based." Discussion: Most recommendations were grade 5, largely because studies to test and validate many recommendations were absent. Recommendation types vary in amount and complexity and, accordingly, the structure and syntax of statements they generate. However, they can be represented in single-decision, branching, and score-based representations. Conclusion: In a curated evidence library with graded imaging-based recommendations, evidence quality varied widely, with decision rules providing the highest-quality recommendations. The library may be helpful in highlighting evidence gaps, comparing recommendations from varied sources on similar clinical topics, and prioritizing imaging recommendations to inform clinical decision support implementation.


Asunto(s)
Sistemas de Apoyo a Decisiones Clínicas , Diagnóstico por Imagen/normas , Práctica Clínica Basada en la Evidencia , Bases del Conocimiento , Humanos , Guías de Práctica Clínica como Asunto
6.
J Cutan Med Surg ; 19(2): 163-6, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25775626

RESUMEN

BACKGROUND: Benign chronic familial pemphigus (BFCP) is an autosomal dominant dermatosis characterized by flares of painful and often debilitating blistering lesions in high friction areas of the body such as the groin, axillae, lateral neck, and intergluteal cleft. Limited knowledge of its pathophysiology has made treatment of BFCP a considerable challenge and efficacy with current first line therapies, topical corticosteroids and antibiotics, is variable. CASE REPORT: We present a case of this disease in a 52 year old woman that has responded dramatically to the addition of oral cyclosporine to her existing regimen of oral acitretin, with significant improvement of skin lesions, mobility, and quality of life. Cyclosporine's mechanism of action in BFCP is poorly understood, although it possibly acts through inhibition of proinflammatory cytokines in keratinocytes or modulation of intracellular calcium. BFCP, the use of cyclosporine for its treatment, and possible mechanisms of action of cyclosporine are reviewed.


Asunto(s)
Ciclosporina/administración & dosificación , Pénfigo Familiar Benigno/tratamiento farmacológico , Administración Oral , Axila , Fármacos Dermatológicos/administración & dosificación , Relación Dosis-Respuesta a Droga , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Cuello , Pénfigo Familiar Benigno/patología , Inducción de Remisión , Piel/patología
7.
JAMA Dermatol ; 151(6): 645, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25671410
9.
Histol Histopathol ; 30(7): 763-70, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25585249

RESUMEN

Despite the efficacy and success of targeted therapies, a significant number of patients with melanoma exhibit either intrinsic or acquired resistance to these drugs. Numerous mechanisms for the development of resistance have been postulated, but the precise reason for this is not known. In this review, we examine the incidence of mutations in select genes (BRAF, NRAS, C-KIT, and GNAQ) known to occur in melanoma, specifically in primary tumors and their paired metastases, to understand the significance of intratumoral heterogeneity by assessing how changes in mutation status alters the process of metastatic spread. Our data revealed a small yet consistent degree of discordance of mutations in the MAPK pathway commonly occurring in melanoma indicating that failed targeted therapy may be a consequence of this.


Asunto(s)
Melanoma/genética , Melanoma/secundario , Mutación , Neoplasias Cutáneas/genética , Análisis Mutacional de ADN , Resistencia a Antineoplásicos/genética , GTP Fosfohidrolasas/genética , Subunidades alfa de la Proteína de Unión al GTP/genética , Subunidades alfa de la Proteína de Unión al GTP Gq-G11 , Humanos , Sistema de Señalización de MAP Quinasas/genética , Melanoma/tratamiento farmacológico , Proteínas de la Membrana/genética , Terapia Molecular Dirigida , Proteínas Proto-Oncogénicas B-raf/genética , Proteínas Proto-Oncogénicas c-kit/genética , Neoplasias Cutáneas/tratamiento farmacológico , Insuficiencia del Tratamiento
10.
J Am Acad Dermatol ; 72(2): 253-60, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25486913

RESUMEN

BACKGROUND: The coexistence of psoriasis and lupus erythematosus (LE) is rare. Anecdotal evidence suggests that anti-tumor necrosis factor alfa (TNF-α) agents may be efficacious in LE, although their use is commonly avoided in this disease because of concern for lupus flare. OBJECTIVE: We sought to describe the epidemiology, serologic findings, and therapeutic choices in patients with coexistent psoriasis/psoriatic arthritis and LE and to determine the risk of lupus flares with TNF-α inhibitors. METHODS: We performed a retrospective multicenter study of patients given the diagnoses of psoriasis (or psoriatic arthritis) and lupus erythematosus (systemic LE or cutaneous LE, including either subacute cutaneous LE or discoid LE) at 2 academic tertiary-care centers. RESULTS: A total of 96 patients with a mean age of 56 years was included. We report higher-than-expected rates of white race and psoriatic arthritis. One clinical lupus flare was observed in a patient receiving a TNF-α inhibitor, resulting in an incidence of 0.92% lupus flares per patient-year of TNF-α inhibitor use. LIMITATIONS: Retrospective chart review, small sample size, and limited documentation. CONCLUSION: Anti-TNF-α agents, ustekinumab, and abatacept may be valid treatment options for patients with concomitant LE and psoriasis. Clinical lupus flares in LE patients treated with TNF-α inhibitors were infrequent.


Asunto(s)
Anticuerpos Monoclonales Humanizados/uso terapéutico , Inmunoconjugados/uso terapéutico , Lupus Eritematoso Cutáneo/complicaciones , Lupus Eritematoso Cutáneo/tratamiento farmacológico , Psoriasis/complicaciones , Psoriasis/tratamiento farmacológico , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Abatacept , Adulto , Anciano , Femenino , Humanos , Lupus Eritematoso Sistémico/complicaciones , Lupus Eritematoso Sistémico/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Resultado del Tratamiento , Ustekinumab
11.
J Cutan Med Surg ; 18(5): 1-4, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25278261

RESUMEN

BACKGROUND: Benign chronic familial pemphigus (BFCP) is an autosomal dominant dermatosis characterized by flares of painful and often debilitating blistering lesions in high friction areas of the body such as the groin, axillae, lateral neck, and intergluteal cleft. Limited knowledge of its pathophysiology has made treatment of BFCP a considerable challenge and efficacy with current first line therapies, topical corticosteroids and antibiotics, is variable. CASE REPORT: We present a case of this disease in a 52 year old woman that has responded dramatically to the addition of oral cyclosporine to her existing regimen of oral acitretin, with significant improvement of skin lesions, mobility, and quality of life. Cyclosporine's mechanism of action in BFCP is poorly understood, although it possibly acts through inhibition of proinflammatory cytokines in keratinocytes or modulation of intracellular calcium. BFCP, the use of cyclosporine for its treatment, and possible mechanisms of action of cyclosporine are reviewed.

13.
JAMA Dermatol ; 150(8): 835, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25133440
14.
Dermatol Pract Concept ; 4(3): 93-6, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25126470

RESUMEN

Tinea versicolor (TV) is a common cutaneous fungal infection characterized by superficial scaling and a mild disturbance of skin pigmentation. It typically affects the chest, upper back, and shoulders. However, involvement of more unusual regions of the body such as the face and scalp, arms and legs, intertriginous sites, genitalia, areolae, and palms and soles has been reported. This report details two such cases observed at our institution: a 32-year-old woman with involvement of the popliteal fossa and a 16-year-old boy with involvement of the groin. The clinician must be aware of these variations in location and perform the appropriate diagnostic workup when lesions have the characteristic morphology of TV despite an unusual location. The etiology, pathophysiology, and epidemiology of TV are reviewed and current literature describing other instances of TV in uncommon locations is discussed.

15.
Expert Rev Clin Pharmacol ; 7(3): 239-50, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24702658

RESUMEN

Psoriatic arthritis occurs in about one-third of patients with psoriasis, and is a severely disabling, progressive inflammatory spondyloarthropathy typically treated with non-steroidal anti-inflammatory drugs, disease-modifying anti-rheumatic drugs, TNF-α inhibitors and ustekinumab. These medications moderately improve the arthritis, dactylitis, and enthesitis that characterize psoriatic arthritis, however, they are associated with serious long-term adverse effects, issues with safety and tolerability, and high cost. Moreover, many patients do not respond or have resistant or recurrent manifestations to these agents. Apremilast is an orally available phosphodiesterase type 4 inhibitor that may block the pathogenic inflammatory Th17 and Th1 pathways upstream of current biologics, which target extracellular molecules of the immunological response.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Artritis Psoriásica/tratamiento farmacológico , Talidomida/análogos & derivados , Administración Oral , Corticoesteroides/administración & dosificación , Corticoesteroides/uso terapéutico , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/efectos adversos , Artritis Psoriásica/inmunología , Biofarmacia , Descubrimiento de Drogas , Humanos , Inyecciones Intraarticulares , Calidad de Vida , Índice de Severidad de la Enfermedad , Talidomida/administración & dosificación , Talidomida/efectos adversos , Talidomida/uso terapéutico , Resultado del Tratamiento
16.
Curr Probl Dermatol ; 45: 197-215, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24643188

RESUMEN

Individuals with inherited immunodeficiencies, autoimmune disorders, organ or bone marrow transplantation and with human immunodeficiency virus are particularly susceptible to developing severe, persistent and extensive manifestations of cutaneous human papillomavirus (HPV) disease. These complex cases require a unique and often multimodal approach to management. In this chapter, we discuss several states of immune compromise with increased susceptibility to HPV disease and review the literature on available management strategies including acitretin, cidofovir, Candida antigen, cimetidine, imiquimod, isotretinoin, fluorouracil, selenium, podophyllotoxin, photodynamic therapy, mammalian target of rapamycin inhibitors and the quadrivalent HPV vaccine.


Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Antivirales/uso terapéutico , Huésped Inmunocomprometido , Infecciones por Papillomavirus/tratamiento farmacológico , Vacunas contra Papillomavirus/uso terapéutico , Enfermedades Cutáneas Virales/tratamiento farmacológico , Antígenos Virales/uso terapéutico , Antioxidantes/uso terapéutico , Humanos , Infecciones por Papillomavirus/inmunología , Enfermedades Cutáneas Virales/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA